OBJECTIVE.: Perform a systematic review to determine the test performance of HPV mRNA
testing compared to DNA testing using CIN2+ as the target condition. METHODS.: We …

Background Genital infection with certain types of Human papillomavirus (HPV) is a major
cause of cervical cancer globally. For early detection of premalignant dysplasia, evidences …

Background Cervical cancer screening tests that identify DNA of the main causal agent, high-
risk human papillomavirus (HPV) types, are more protective than cervical cytology. We …

Objectives This study determined the longitudinal clinical performance of a high-risk human
papillomavirus (HR-HPV) E6/E7 RNA assay (Aptima HPV [AHPV]; Hologic, San Diego, CA) …

OBJECTIVE: This is a meta-analysis of studies comparing HPV testing to cytology with
regard to their accuracy in the detection of underlying high grade cervical intraepithelial …

Human‐papillomavirus (HPV) DNA testing has been proposed as an alternative to primary
cervical cancer screening using cytological testing. Review of the evidence shows that …

OBJECTIVE: New commercial HPV RNA assays require further validation studies in
population-based cervical cancer screening settings. To assess the performance of (FDA …

Randomized clinical trials using human papillomavirus (HPV) DNA testing have found
increased protection against cervical cancer and HPV‐based screening is globally …

OBJECTIVE: The objective of the study was to investigate whether knowledge of human
papillomavirus (HPV) deoxyribonucleic acid test results increases sensitivity of guided …

Objective The human papillomavirus (HPV) test is an effective screening tool to prevent
cervical cancer. Urinary sampling for HPV detection improves the accessibility and …